{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:56:56Z","timestamp":1790935016590,"version":"4.1.0"},"reference-count":40,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: First-line treatment selection for advanced (locally advanced or metastatic) pancreatic ductal adenocarcinoma (PDAC) is currently based on clinical characteristics rather than predictive biomarkers. While homologous recombination deficiency (HRD) is associated with increased sensitivity to platinum-based chemotherapy, established predictive biomarkers, such as pathogenic alterations in BRCA1, BRCA2, and PALB2, identify only a small subset of patients who are likely to benefit from platinum-based first-line treatment. The Genomic Instability Score (GIS) may capture broader HRD-associated genomic scarring beyond single-gene testing and support biomarker-guided platinum selection. However, the clinical utility of the GIS in PDAC remains uncertain, and no PDAC-specific GIS cutoff has yet been established. Methods: In this retrospective multicenter cohort, 127 patients with advanced PDAC underwent TruSight Oncology 500 HRD testing between 2022 and 2025. GIS was evaluable in 99 patients; 80 received first-line therapy. The primary endpoint was time to failure of the first-line strategy (TFS). An exploratory candidate GIS cutoff for platinum sensitivity was identified using maximally selected log-rank statistics, and survival was analyzed using Kaplan\u2013Meier estimates and Cox regression. Results: In the first-line platinum cohort, an exploratory GIS threshold of 39 showed the greatest discrimination for treatment failure-free survival (TFS) within this cohort. Patients with GIS \u2265 39 had significantly longer TFS than those with GIS &lt; 39 (9.9 vs. 5.9 months; HR 0.33, 95% CI 0.13\u20130.80; p = 0.015), and this association remained significant after multivariable adjustment. Among individual genes, BRCA2-mutated tumors exhibited significantly higher GIS than BRCA2-wild-type tumors (median 54 vs. 19; FDR-adjusted p = 0.002), although 30% of GIS-high tumors lacked BRCA1\/2 mutations. Combined stratification by GIS and first-line treatment demonstrated a stepwise improvement in overall survival, with median OS of 8.2 months in non-platinum\/GIS &lt; 39 patients, 15.1 months in platinum\/GIS &lt; 39 patients, and 30.7 months in platinum\/GIS \u2265 39 patients (p = 0.002). Conclusions: GIS may identify patients with advanced PDAC who experience favorable outcomes during first-line platinum-based chemotherapy. The observed association between higher GIS and improved treatment outcomes supports further investigation of GIS as a biomarker for treatment stratification in advanced PDAC and warrants prospective validation.<\/jats:p>","DOI":"10.3390\/jcm15197632","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:10:48Z","timestamp":1790932248000},"page":"7632","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding Genomic Instability Score in Platinum-Treated Advanced Pancreatic Ductal Adenocarcinoma"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0445-1986","authenticated-orcid":false,"given":"Justus","family":"Leinhos","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria"},{"name":"Faculty of Medicine, Johannes Kepler University Linz, 4020 Linz, Austria"},{"name":"Department of Internal Medicine III, Hematology and Oncology, LMU University Hospital, 81377 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4244-7954","authenticated-orcid":false,"given":"Theodora","family":"Malli","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Genetic Diagnostics, Ordensklinikum Linz, 4010 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Anna","family":"Gabler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"software","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9690-2293","authenticated-orcid":false,"given":"Daniel","family":"Nothdurfter","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1319-9798","authenticated-orcid":false,"given":"Andreas","family":"Reichinger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria"},{"name":"Faculty of Medicine, Johannes Kepler University Linz, 4020 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6720-4671","authenticated-orcid":false,"given":"Jonathan","family":"Burghofer","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Johannes Kepler University Linz, 4020 Linz, Austria"},{"name":"Laboratory for Molecular Genetic Diagnostics, Ordensklinikum Linz, 4010 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Stefan","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Genetic Diagnostics, Ordensklinikum Linz, 4010 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Johann","family":"Mandl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV for Hematology and Medical Oncology, Hospital Wels-Grieskirchen, 4600 Wels, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Georg","family":"Schreil","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II for Medical Oncology, State Hospital Pyhrn-Eisenwurzen, 4400 Steyr, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Alexander","family":"Andorfer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I for Hematology and Medical Oncology, Sisters of Charity Hospital Ried, 4910 Ried im Innkreis, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Hannes","family":"Windhager","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Karl J.","family":"Aichberger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, State Hospital Rohrbach, 4150 Rohrbach, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2806-4594","authenticated-orcid":false,"given":"Patrick","family":"Kirchweger","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Johannes Kepler University Linz, 4020 Linz, Austria"},{"name":"Department of Surgery, Ordensklinikum Linz, 4010 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Florian","family":"Primavesi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ordensklinikum Linz, 4010 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5654-6190","authenticated-orcid":false,"given":"Gerald","family":"Webersinke","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Johannes Kepler University Linz, 4020 Linz, Austria"},{"name":"Laboratory for Molecular Genetic Diagnostics, Ordensklinikum Linz, 4010 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4118-0111","authenticated-orcid":false,"given":"Holger","family":"Rumpold","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4813-4435","authenticated-orcid":false,"given":"Bernhard","family":"Doleschal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria"},{"name":"Faculty of Medicine, Johannes Kepler University Linz, 4020 Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"project-administration","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: A review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.20.03238","article-title":"Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis","volume":"39","author":"Casolino","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1158\/1078-0432.CCR-20-0418","article-title":"Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection","volume":"26","author":"Park","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/oncolo\/oyad178","article-title":"A novel HRD signature is predictive of FOLFIRINOX benefit in metastatic pancreatic cancer","volume":"28","author":"Chen","year":"2023","journal-title":"Oncologist"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"105827","DOI":"10.1016\/j.esmoop.2025.105827","article-title":"NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: An exploratory analysis of real-world data","volume":"10","author":"Reichinger","year":"2025","journal-title":"ESMO Open"},{"key":"ref_6","first-page":"603","article-title":"NCCN guidelines updates: Pancreatic cancer","volume":"17","author":"Tempero","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Yu, J., Cao, Y., Xia, F., Lan, Q., Zhou, J., Wang, Z., and Ren, S. (2026). Diagnostic performance of multislice spiral computed tomography in differentiating pancreatic acinar cell carcinoma from pancreatic ductal adenocarcinoma. Abdom. Radiol., Epub ahead of print.","DOI":"10.1007\/s00261-026-05617-8"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41698-025-00843-7","article-title":"Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm","volume":"9","author":"Cheng","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e70029","DOI":"10.1002\/2056-4538.70029","article-title":"Emerging pathological diagnostic strategies for solid pseudopapillary neoplasm of the pancreas: Insights from omics and innovative techniques","volume":"11","author":"Liu","year":"2025","journal-title":"J. Pathol. Clin. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1007\/s00330-024-10837-x","article-title":"Differentiating small (<2 cm) pancreatic ductal adenocarcinoma from neuroendocrine tumors with multiparametric MRI-based radiomic features","volume":"34","author":"Shen","year":"2024","journal-title":"Eur. Radiol."},{"key":"ref_11","first-page":"e70035","article-title":"Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future","volume":"76","author":"Mannucci","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15353508241245265","DOI":"10.1177\/15353508241245265","article-title":"Combining Nuclear Medicine With Other Modalities: Future Prospect for Multimodality Imaging","volume":"23","author":"Archibald","year":"2024","journal-title":"Mol. Imaging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1053\/j.gastro.2021.01.220","article-title":"Genomic features and classification of homologous recombination deficient pancreatic ductal adenocarcinoma","volume":"160","author":"Golan","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13048-023-01129-x","article-title":"Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma","volume":"16","author":"Feng","year":"2023","journal-title":"J. Ovarian Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100031","DOI":"10.1016\/j.ijgc.2024.100031","article-title":"Comprehensive evaluation of genomic and functional assays for homologous recombination deficiency with high-grade epithelial ovarian cancer: Platinum sensitivity and prognosis","volume":"35","author":"Feng","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"oyaf141","DOI":"10.1093\/oncolo\/oyaf141","article-title":"The prognostic and predictive value of homologous recombination deficiency in gastrointestinal cancer","volume":"30","author":"Jiang","year":"2025","journal-title":"Oncologist"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.semcancer.2025.05.005","article-title":"Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer","volume":"113","author":"Selvi","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4143\/crt.2024.154","article-title":"Recent advances in genomic approaches for the detection of homologous recombination deficiency","volume":"56","author":"Kim","year":"2024","journal-title":"Cancer Res. Treat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40364-025-00740-y","article-title":"Homologous recombination deficiency (HRD) testing landscape: Clinical applications and technical validation for routine diagnostics","volume":"13","author":"Witz","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Mark, L.R., Terp, S.K., Krarup, H.B., Thomassen, M., Pedersen, I.S., and B\u00f8gsted, M. (2023). Homologous recombination deficiency detection algorithms: A systematic review. Cancers, 15.","DOI":"10.3390\/cancers15235633"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ottestad, A.L., Huang, M., Emdal, E.F., Mjelle, R., Skarpeteig, V., and Dai, H.Y. (2023). Assessment of two commercial comprehensive gene panels for personalized cancer treatment. J. Pers. Med., 13.","DOI":"10.3390\/jpm13010042"},{"key":"ref_22","unstructured":"Illumina (2025). TruSight Oncology 500 HRD Data Sheet; M-GL-00748 V6.0, Illumina, Inc.. Available online: https:\/\/www.illumina.com\/content\/dam\/illumina\/gcs\/assembled-assets\/marketing-literature\/tso500-hrd-data-sheet-m-gl-00748\/tso500-hrd-data-sheet-m-gl-00748.pdf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"D835","DOI":"10.1093\/nar\/gkz972","article-title":"ClinVar: Improvements to accessing data","volume":"48","author":"Landrum","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"D1210","DOI":"10.1093\/nar\/gkad986","article-title":"COSMIC: A curated database of somatic variants and clinical data for cancer","volume":"52","author":"Sondka","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: The human genomic variant search engine","volume":"35","author":"Kopanos","year":"2019","journal-title":"Bioinformatics"},{"key":"ref_26","unstructured":"SOPHiA GENETICS (2026, July 20). Alamut Visual Plus, Version 1.6.1. Available online: https:\/\/www.sophiagenetics.com\/platform\/alamut-visual-plus\/."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.ajhg.2025.08.020","article-title":"Specifications of the ACMG\/AMP variant curation guidelines for the analysis of germline PALB2 sequence variants","volume":"112","author":"Richardson","year":"2025","journal-title":"Am. J. Hum. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"103630","DOI":"10.1016\/j.esmoop.2024.103630","article-title":"Understanding homologous recombination repair deficiency in biliary tract cancers: Clinical implications and correlation with platinum sensitivity","volume":"9","author":"Mavroeidi","year":"2024","journal-title":"ESMO Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2600011","DOI":"10.1200\/PO-26-00011","article-title":"Time to Treatment Failure as an End Point in Pragmatic Oncology Trials: Association With Progression-Free Survival Across Randomized Studies","volume":"10","author":"Dalrymple","year":"2026","journal-title":"JCO Precis. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_32","unstructured":"(2016). Regulation (EU) 2016\/679 of the European Parliament and of the Council of 27 April 2016 on the Protection of Natural Persons with Regard to the Processing of Personal Data and on the Free Movement of Such Data, and Repealing Directive 95\/46\/EC (General Data Protection Regulation) (Standard No. Regulation (EU) 2016\/679)."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-006-9242-8","article-title":"Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. Reporting recommendations for tumor MARKer prognostic studies (REMARK)","volume":"100","author":"McShane","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2023.10.001","article-title":"ESMO Guidance for Reporting Oncology real-World evidence (GROW)","volume":"34","author":"Pellat","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100003","DOI":"10.1016\/j.esmorw.2023.10.001","article-title":"ESMO Guidance for Reporting Oncology real-World evidence (GROW)","volume":"1","author":"Pellat","year":"2023","journal-title":"ESMO Real World Data Digit. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e17543","DOI":"10.1200\/JCO.2024.42.16_suppl.e17543","article-title":"Homologous recombination deficiency score for predicting efficacy of platinum-based chemotherapy and PARPi maintenance therapy in ovarian cancer","volume":"42","author":"Wang","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"van der Wiel, A.M.A., Schuitmaker, L., Cong, Y., Theys, J., Van Hoeck, A., Vens, C., Lambin, P., Yaromina, A., and Dubois, L.J. (2022). Homologous Recombination Deficiency Scar: Mutations and Beyond\u2014Implications for Precision Oncology. Cancers, 14.","DOI":"10.3390\/cancers14174157"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00087","article-title":"Homologous Recombination Deficiency in Patients With Pancreatic Ductal Adenocarcinoma and Response to Chemotherapy","volume":"2","author":"Shahda","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"101291","DOI":"10.1016\/j.drup.2025.101291","article-title":"Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy","volume":"83","author":"Wang","year":"2025","journal-title":"Drug Resist. Updat."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7632\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:20:56Z","timestamp":1790932856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":40,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197632"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197632","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}